Welcome to our dedicated page for Linkage Global news (Ticker: UZX), a resource for investors and traders seeking the latest updates and insights on Linkage Global stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Linkage Global's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Linkage Global's position in the market.
Linkage Global (NASDAQ: UZX) announced that Professor Zeng Yan, Chief Scientist at ClickClack, an intellectual property partner of Linkage Global, received the “Clinical Contribution Award for Deep Coma Awakening” from the Coma Arousal and Rehabilitation Center for Brain Disorders at Guangdong Second Hospital of Traditional Chinese Medicine.
The award recognizes a two-year, uncontrolled, single-center observational study in 407 deep coma patients using a non-invasive protocol combining “micro-brain” sound wave music with traditional acupuncture. According to Linkage Global, 32 patients (7.86%) awakened and 252 (61.9%) showed ≥9-point increases on the Glasgow Coma Scale, but the company cautions these outcomes cannot be attributed to the protocol, are not evidence of safety or efficacy, and have not been peer reviewed or assessed by regulators.
Building on these data, Linkage Global and the Hospital are starting a second-stage (“Phase II”) investigational research program on non-pharmacological approaches to cognitive impairment and sleep disorders, which is not a regulated clinical trial phase and carries no assurance of completion, positive results, or commercial products.
Linkage Global (NASDAQ: UZX) announced on August 11, 2026 that it is evaluating opportunities to apply its AI-enabled acoustic wellness technology in the hotel and hospitality sector. The proposed Emotional Frequency Tuning hotel empowerment solution would integrate acoustic algorithms and smart hardware into guest rooms, spas, and wellness spaces.
According to the company, potential deployments could use Frequency Following Response technology, proprietary acoustic instruments, and nature sound libraries, combined with ClickClack smart headphones, resonance massage pads, and ambient soundscape systems. Linkage Global is assessing possible commercial partnerships, but no hotel agreements have been entered into so far.
Linkage Global (NASDAQ: UZX) announced a strategic transformation into an AI-driven psychoacoustics and wellness infrastructure platform centered on its new Human Resonance OS, moving beyond traditional hardware and e-commerce models. Hardware, led by licensed smart headphones, will primarily function as a data and user acquisition layer for a higher-margin digital ecosystem.
The Human Resonance OS is designed to combine proprietary AI neural audio algorithms, real-time emotional computing, and cloud-based wellness services. It connects elements such as original wellness audio copyrights, AI digital companionship, an upcoming AI wellness app, and deployments in smart homes, corporate wellness, AI pods, and immersive “sonic cinema” environments.
Linkage Global (NASDAQ: UZX) reported unaudited results for the six months ended March 31, 2026. Total revenues fell 25.22% to $2.62 million, while gross profit declined 10.43% to $2.42 million. Net loss narrowed 45.91% to $1.67 million.
Integrated e-commerce services revenue dropped 30.01% to $1.89 million and cross-border sales decreased 98.97% to $8,278. A new headset trademark and patent licensing business contributed $720,000 at 100% gross margin. Operating expenses decreased 5.04% to $4.12 million, with general and administrative expenses down 44.90%.
Linkage Global (NASDAQ: UZX) announced a strategic upgrade to build a global AI-enabled wellness ecosystem, combining generative AI, proprietary music copyrights and smart wearable hardware.
The company expects about $8 million in annual partnership revenue and reports ClickClack licensed smart headphone sales trending toward $1 million in monthly revenue.
Linkage Global (Nasdaq: UZX) received a Nasdaq notice on June 3, 2026 that its Class A shares no longer meet the $1 minimum bid price requirement under Rule 5550(a)(2) after 30 consecutive business days below that level.
The notice does not immediately affect listing or trading, and UZX will continue on Nasdaq. Linkage Global has a 180-day compliance period until November 30, 2026, with a possible additional 180 days if certain criteria are met. The company is evaluating options, including a potential reverse stock split, but warns there is no assurance it will regain compliance or satisfy all continued listing requirements.
Linkage Global (NASDAQ: UZX) authorized a $8 million share repurchase program for its Class A ordinary shares. The move follows a recent corporate rebranding and Nasdaq ticker change to UZX and is planned to be funded with existing cash and future cash flow.
Repurchases may occur via open market, private deals, block trades or other permitted methods, with timing and size determined by capital position, liquidity, performance and market conditions. The program is discretionary and can be modified, suspended or discontinued.